Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast
Bruker Corporation (NASDAQ: BRKR) will report its first quarter 2022 financial results on May 4, 2022, before market opening. A conference call and webcast will take place at 8:30 a.m. Eastern Time to discuss these results and current business trends. Investors can access the webcast through Bruker's investor relations website or via telephone. A replay will be available starting one hour after the call until June 4, 2022. Bruker continues to support scientific innovation and diagnostics in various research fields.
- Scheduled financial results announcement for Q1 2022, indicating ongoing operations and transparency.
- Conference call provides opportunity for direct investor engagement and insight into business trends.
- None.
To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2022 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentation will be referenced during the webcast and will be posted to the Company’s website shortly before the webcast begins.
Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (
Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite their entry into the call and avoid the need to wait for a live operator. In order to pre-register for the call, investors can visit https://dpregister.com/sreg/10166284/f2709dc120 and enter their contact information. Investors will then be issued a personalized phone number and PIN to dial into the live conference call. Individuals can pre-register any time prior to the start of the conference call on
A telephone replay of the conference call will be available by dialing 1-877-344-7529 (
About
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220418005487/en/
Sr. Director, Investor Relations & Corporate Development
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com
Source:
FAQ
When will Bruker Corporation report its Q1 2022 financial results?
What time is the conference call for Bruker Corporation's Q1 2022 results?
How can I listen to the Bruker Q1 2022 earnings call?
Is there a replay available for Bruker's Q1 2022 earnings call?
